Baxter Home
Conditions Therapies Products Services About Baxter
Training and Education Sustainability Contact Us
 

Baxter in the News

 
 
  • National Hemophilia Foundation Asks America to Make a Difference with National Fundraising Initiative - April 17, 2008
  • Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year - September 12, 2007
  • Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at the University of California-San Francisco - May 14, 2007
  • Jeffrey Modell Foundation Funds Molecular Diagnostic Laboratory for Primary Immunodeficiencies at Seattle Children's Hospital Research Institute - May 11, 2007
  • Baxter Added to the U.S. EPA's "Fortune 500 Challenge" List - April 30, 2007
  • New Baxter Program Surrounds Alpha-1 Patients, Physicians with Support - March 27, 2007
  • Kuros receives orphan drug designation for solitary bone cysts product - February 26, 2007
  • Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at Children's Hospital of Wisconsin - January 18, 2007
  • Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at the Louisiana State University Health Sciences Center - December 1, 2006
  • Baxter, Chicago Climate Exchange Announce First-of-its-Kind Transaction (pdf) - May 4, 2006
  • Statement of Ron Meissen, Senior Director, Environment, Health and Safety Engineering, Baxter International Inc. Regarding Climate Change Before the Science Committee of the House of Representatives - June 8, 2005
  • GHX Honors Baxter as Healthcare Supplier of the Year - May 16, 2005
  • Baxter Recognized by Business Ethics magazine As One of "100 Best Corporate Citizens" - Spring 2005
  • NewYork-Presbyterian/Weill Cornell Study Finds IVIG Therapy May Improve Cognitive Function in Alzheimer's Patients - April 11, 2005
     

 
Copyright & Legal Disclaimer  |  Privacy  |   Print this page